Literature DB >> 23959176

IFN-β-specific signaling via a unique IFNAR1 interaction.

Surinder Kaur1, Leonidas C Platanias.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23959176     DOI： 10.1038/ni.2686

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  15 in total

1.  The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY.

Authors:  Scott A Ezell; Christos Polytarchou; Maria Hatziapostolou; Ailan Guo; Ioannis Sanidas; Teeru Bihani; Michael J Comb; George Sourvinos; Philip N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

Review 2.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

3.  Regulatory effects of mTORC2 complexes in type I IFN signaling and in the generation of IFN responses.

Authors:  Surinder Kaur; Antonella Sassano; Beata Majchrzak-Kita; Darren P Baker; Bing Su; Eleanor N Fish; Leonidas C Platanias
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-01       Impact factor: 11.205

4.  Differential receptor subunit affinities of type I interferons govern differential signal activation.

Authors:  Eva Jaks; Martynas Gavutis; Gilles Uzé; Jacques Martal; Jacob Piehler
Journal:  J Mol Biol       Date:  2006-11-18       Impact factor: 5.469

5.  The stability of the ternary interferon-receptor complex rather than the affinity to the individual subunits dictates differential biological activities.

Authors:  Eyal Kalie; Diego A Jaitin; Yulia Podoplelova; Jacob Piehler; Gideon Schreiber
Journal:  J Biol Chem       Date:  2008-09-18       Impact factor: 5.157

6.  The human type I interferon receptor. Identification of the interferon beta-specific receptor-associated phosphoprotein.

Authors:  E Croze; D Russell-Harde; T C Wagner; H Pu; L M Pfeffer; H D Perez
Journal:  J Biol Chem       Date:  1996-12-27       Impact factor: 5.157

7.  Role of the Akt pathway in mRNA translation of interferon-stimulated genes.

Authors:  Surinder Kaur; Antonella Sassano; Blazej Dolniak; Sonali Joshi; Beata Majchrzak-Kita; Darren P Baker; Nissim Hay; Eleanor N Fish; Leonidas C Platanias
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-13       Impact factor: 11.205

8.  Differences in interferon alpha and beta signaling. Interferon beta selectively induces the interaction of the alpha and betaL subunits of the type I interferon receptor.

Authors:  L C Platanias; S Uddin; P Domanski; O R Colamonici
Journal:  J Biol Chem       Date:  1996-09-27       Impact factor: 5.157

9.  Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta.

Authors:  C Abramovich; L M Shulman; E Ratovitski; S Harroch; M Tovey; P Eid; M Revel
Journal:  EMBO J       Date:  1994-12-15       Impact factor: 11.598

Review 10.  Interferons at age 50: past, current and future impact on biomedicine.

Authors:  Ernest C Borden; Ganes C Sen; Gilles Uze; Robert H Silverman; Richard M Ransohoff; Graham R Foster; George R Stark
Journal:  Nat Rev Drug Discov       Date:  2007-12       Impact factor: 84.694
View more
  7 in total

1.  Medium dose intermittent cyclophosphamide induces immunogenic cell death and cancer cell autonomous type I interferon production in glioma models.

Authors:  Bin Du; David J Waxman
Journal:  Cancer Lett       Date:  2019-11-22       Impact factor: 8.679

2.  Central role of ULK1 in type I interferon signaling.

Authors:  Diana Saleiro; Swarna Mehrotra; Barbara Kroczynska; Elspeth M Beauchamp; Pawel Lisowski; Beata Majchrzak-Kita; Tushar D Bhagat; Brady L Stein; Brandon McMahon; Jessica K Altman; Ewa M Kosciuczuk; Darren P Baker; Chunfa Jie; Nadereh Jafari; Craig B Thompson; Ross L Levine; Eleanor N Fish; Amit K Verma; Leonidas C Platanias
Journal:  Cell Rep       Date:  2015-04-16       Impact factor: 9.423

Review 3.  Type I interferons in anticancer immunity.

Authors:  Laurence Zitvogel; Lorenzo Galluzzi; Oliver Kepp; Mark J Smyth; Guido Kroemer
Journal:  Nat Rev Immunol       Date:  2015-06-01       Impact factor: 53.106

Review 4.  Interferon receptor signaling in malignancy: a network of cellular pathways defining biological outcomes.

Authors:  Eleanor N Fish; Leonidas C Platanias
Journal:  Mol Cancer Res       Date:  2014-09-12       Impact factor: 5.852

5.  TLR3-driven IFN-β antagonizes STAT5-activating cytokines and suppresses innate type 2 response in the lung.

Authors:  Rinna Tei; Koji Iijima; Koji Matsumoto; Takao Kobayashi; Jyoti Lama; Elizabeth A Jacobsen; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2021-08-21       Impact factor: 10.793

Review 6.  Getting "Inside" Type I IFNs: Type I IFNs in Intracellular Bacterial Infections.

Authors:  Deann T Snyder; Jodi F Hedges; Mark A Jutila
Journal:  J Immunol Res       Date:  2017-04-26       Impact factor: 4.818

Review 7.  Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across.

Authors:  An-Katrien Minnaert; Helena Vanluchene; Rein Verbeke; Ine Lentacker; Stefaan C De Smedt; Koen Raemdonck; Niek N Sanders; Katrien Remaut
Journal:  Adv Drug Deliv Rev       Date:  2021-07-26       Impact factor: 17.873
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.